Depression and pain: Often together but still a clinical challenge - A review

Psychiatria Danubina

Volumn 24, Issue 4, 2012, Pages 346-352

  Rijavec, Nikolina ^a   Grubic, Virginija Novak ^a  

^a UNIVERSITY PSYCHIATRIC HOSPITAL   (Slovenia)

Author keywords

Depression; Neurobiology; Pain; Treatment; Unexplained painful physical symptoms

Indexed keywords

AMFEBUTAMONE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DULOXETINE; GABAPENTIN; MILNACIPRAN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NEUROTRANSMITTER; NOCICEPTIN; OLANZAPINE; PREGABALIN; QUETIAPINE; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; ZIPRASIDONE;

ANALGESIA; ANALGESIC ACTIVITY; ANXIETY DISORDER; CANCER PAIN; CHRONIC PAIN; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; FIBROMYALGIA; HUMAN; MAJOR DEPRESSION; MEDICAL RESEARCH; MENTAL PATIENT; NEUROPATHIC PAIN; NEUROTRANSMISSION; NOCICEPTION; OCCUPATIONAL THERAPY; PAIN; PAIN ASSESSMENT; PSYCHIATRIST; PSYCHOEDUCATION; PSYCHOPHARMACOTHERAPY; RELAXATION TRAINING; REVIEW; SOMATIZATION; SOMATOFORM DISORDER; STRESS; VISUAL ANALOG SCALE;

ANTIDEPRESSIVE AGENTS; BIOFEEDBACK, PSYCHOLOGY; COGNITIVE THERAPY; DEPRESSIVE DISORDER; HUMANS; NEURAL PATHWAYS; PAIN; PSYCHOTHERAPY;

EID: 84873603787     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Aguera L, Failde I, Cervilla JA, Diaz-Fernandez P, Mico JA: Medically unexplained pain complaints are associated with underlying unrecognized mood disorders in primary care. BMC Fam Pract 2010; 11: 17.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association 2000.
3. Anič N: Vedenjsko-kognitivna terapija depresije. In Romih J, Žmitek A (eds): Zdravljenje z antidepresivi. Begunje, 1996.
4. Arnow BA: Relationships between childhood maltreatment, adult health and psychiatric outcomes, and medical utilization. J Clin Psychiatry 2004; 65 (suppl. 12): 10-15.
5. Arnow BA, Hunkeler EM, Blasey CM, Lee J, Constantino MJ, Fireman B, et al.: Comorbid depression, chronic pain, and disability in primary care. Psychosom Med 2006; 68: 262-8.
6. Bair MJ, Eckert GJ, Robinson RL, Stang PE, Croghan TW, Kroenke K, et al.: Impact of pain on depression treatment efficacy. J Gen Intern Med 2000; 17: 183.
7. Begre S, Traber M, Gerber M, von Kanel R: Change in pain severity with open label venlafaxine use in patients with a depressive symptomatology: an observational study in primary care. Eur Psychiatry 2008; 23: 178-86.
8. Blackburn-Munro G & Blackburn-Munro RE: Chronic pain, chronic stress and depression: coincidence or consequence? J Neuroendocrinol 2001; 13: 1009-23.
9. Blackburn-Monro G: Hypothalamic-pituitary-adrenal axis dysfunction as a contributory factor to chronic pain and depression. Curr Pain Headeache Rep 2004; 8: 116-24.
10. Braš M, Dordević V, Gregurek R, Bulajić M: Neurobiological and clinical relationship between psychiatric disorders and chronic pain. Psychiatr Danub 2010; 22: 221-6.
11. Breder CD & Conway CM: Pain systems: interface with the affective brain. In Sadock BJ & Sadock AV (eds): Kaplan & Sadock's Comprehensive textbook of psychiatry, 341-45. Lippincott Williams & Wilkins, 2009.
12. Briley M, Moret C: Treatment of comorbid pain with serotonin norepinephrine reuptake inhibitors. CNS Spectr 2008; 13 (suppl 11): 22-6.
13. Deak T, Bordner KA, McElderry NK, Barnum CJ, Blandino P Jr, Deak MM, et al.: Stress-induced increases in hypothalamic IL-1: a systematic comparison of multiple stressor paradigms. Brain Res Bull 2005; 64: 541-56.
14. Dowrick C, Katona C, Peveler R, Lloyd H: Somatic symptoms and depression: diagnostic confusion and clinical neglect. Br J Gen Pract 2005; 55: 829-30.
15. Elman I, Zubieta JK, Borsook D: The missing p in psychiatric training: why it is important to teach pain to psychiatrists. Arch Gen Psychiatry 2011; 68: 12-20.
16. Ericsson M, Poston WSC, Linder J, Taylor JE, Haddock K, Foreyt JP, et al.: Depression predicts disability in long term chronic pain patient. Disabil Rehabil 1996; 24: 334-40.
17. Ettinger AB & Argoff CE: Use of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain. Neurotherapeutics 2007; 4: 75-83.
18. Fava M: Depression with physical symptoms: treating to remission. J Clin Psychiatry 2003; 64 (suppl. 7): 24-8.
19. Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM: The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? J Clin Psychiatry 2004; 65: 523-30.
20. Fietta P, Fietta P, Manganelli P: Fibromyalgia and psychiatric disorders. Acta Biomed 2007; 78: 88-95.
21. Fishbain DA: Approaches to treatment decisions for psychiatric comorbidity in the management of the chronic pain patient. Med Clin North Am 1999; 83: 737-760.
22. Fishbain DA: Evidence-based treatment paradigms for depressed patients with pain and physical symptoms. J Clin Psychiatry 2009; 70:e22.
23. Forrest AJ & Wolkind SN: Masked depression in man with low back pain. Rheumatol Rehabil 1974; 13: 1485-53.
24. Garcia-Cebrian A, Gandhi P, Demyttenaere K, Peveler R: The association of depression and painful physical symptoms - a review of European literature. Eur Psychiatry 2006; 21: 379-88.
25. Geerlings SW, Twisk JW, Beekman AT, Deeg DJ, van Tilburg W: Longitudinal relationship between pain and depression in older adults: sex, age and pain disability. Soc Psychiatry Psychiatr Epidemiology 2002; 37: 23-30.
26. Goldenberg DL: Pain/depression dyad: a key to a better understanding and treatment of functional somatic syndromes. Am J Med 2010; 123: 675-82.
27. Greden JF: Physical symptoms of depression: unmet needs. J Clin Psychiatry 2003; 64 (suppl. 7): 5-11.
28. Greenberg PE, Leong SA, Birnbaum HG, Robinson RL: The economic burden of depression with painful symptoms. J Clin Psychiatry 2003; 64: 17-3.
29. Gureje O, Von Korff M, Simon GE: Persistent pain and well-being: A WHO study in primary care. JAMA 1998; 280: 147-151.
30. Gureje O: Psychiatric aspects of pain. Curr Opin Psychiatry 2007; 20: 42-6.
31. Henningsen P, Zimmermann T, Sattel H: Medically unexplained physical symptoms, anxiety, and depression: a meta analytical review. Psychosom Med 2003; 65: 528-33.
32. Hartman JM, Berger A, Baker K, Bolle J, Handel D, Mannes A et al.: Quality of life and pain in premenopausal women with major depressive disorder: the POWER Study, 2006. Available at www.hqlo.com/content/4/1/2.
33. Husain MM, Rush AJ, Trivedi MH, McClintock SM, Wisniewski SR, Davis L, et al.: Pain in depression: STAR*D study findings. J Psychosom Res 2007; 63 (suppl. 2): 113-22.
34. ICD-10 classification of mental and behavioral disorders: clinical description and diagnostic guidelines. World Health Organisation, Geneva, Switzerland, 1992.
35. Katona C, Peveler R, Dowrick C, Wesswley S, Feinmann C, Gask L et al.: Pain symptoms in depression: definition and clinical significance. Clin Med 2005; 5: 390-5.
36. Kim YK, Na KS, Shin KH, Jung HY, Choi SH, Kim JB: Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1044-53.
37. Kores Plesničar B: Osnove psihofarmakoterapije. Dravska tiskarna, Maribor, 2007.
38. Leuchter AF, Husain MM, Cook IA, Trivedi MH, Wisniewski SR, Gilmer WS, et al.: Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relive Depression) report. Psychol Med 2010; 40 (suppl. 2): 239-51.
39. Maj M, Sartorius N, Tasman A, Gureje O: WPA educational programme on depressive disorders, Volume I. The World Psychiatric Association, 2008a.
40. Maj M, Sartorius N, Tasman A, Gureje O: WPA educational programme on depressive disorders, Volume II. The World Psychiatric Association, 2008b.
41. Marks DM, Shah MJ, Patkar AA, Masand PS, Park GY: Serotonin- norepinephrine reaptake inhibitors for pain control: premise and promise: Curr Neuropharmacology 2009; 7: 331-6.
42. Max MB, Lynch SA, Muir I, Shoaf SE, Smoller B, Dubner R: Effects of desipramine, amitriptyline and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326: 1250-6.
43. Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, et al.: Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA (A) receptor subunits in frontal cortical brain regions. J Neurosci 2004; 24: 1478-85.
44. Merskey H, Lindblom U, Mumford JM, Nathan PW, Noordenbos W, Sunderland SS: Pain terms: a current list with definitions and notes usage. Pain 1986; S215: 21.
45. Mohr P, Bitter I, Švestka J, Seifritz E, Karamustafalioglu O, Koponen H et al.: Management of depression in the presence of pain symptoms. Psychiatr Danub 2010; 22: 4-13.
46. Murray DJ & Lopez AD: The global burden of disease: a comprehensive assessment of morality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Harvard School of Public Health in behalf of the World Health Organization and the Word Bank, Cambridge, MA, 1996.
47. Ohayon MM & Schatzberg AF: Using chronic pain to predict depressive morbidity in general population. Arch Gen Psychiatry 2003; 60: 39-47.
48. Ohayon MM: Specific Characteristics of the pain/depression association in the general population. J Clin Psychiatry 2004; 65: (suppl. 12): 5-9.
49. Panzarino PJ: The costs of depression: direct and indirect; treatment versus nontreatment. J Clin Psychiatry 1998; 59 (suppl. 20): 11-4.
50. Peveler R, Katona C, Wessley S, Dowrick C: Painful symptoms in depression: under-recognized and undertreated? Br J Psychiatry 2006; 188: 202-3.
51. Phillips ML, Drevets WC, Rauch SL, Lane R: Neurobiology of emotion perception I: The neuronal basis of normal emotion perception. Biol Psychiatry 2003; 54: 504-14.
52. Pittinger C, Durman RS: Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008; 33 (suppl. 1): 88-109.
53. Sartorius N: Physical symptoms of depression as a public health concern. J Clin Psychiatry 2003; 64 (suppl. 7): 3-4.
54. Schatzberg AF: The relationship of chronic pain and depression. J Clin Psychiatry 2004; 65 (suppl. 12): 3-4.
55. Schneider E, Linden M, Wiegmann H, Wagner T, Quail D, Hundemer HP, et al.: Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine. BMC Psychiatry 2011; 11: 150.
56. Schrocksnadel K, Wirleitner B, Winkler C, Fuchs D: Monitoring tryptophan metabolism in chronic immune activation. Clin Chem Acta 2006; 364: 82-90.
57. Simon GE, Von Korff M: Suicide mortality among patients treated for depression in an insured population. Am J Epidemiol 1998; 147: 155-60.
58. Simon GE, Von Korff M, Piccinelli M, Fullerton C, Ormel J: An international study of the relation between somatic symptoms and depression. N Engl J Med 1999; 341: 1329-35.
59. Stahl SM: Stahl's Essential Psychopharmacology. 3rd ed. University Press, Cambridge, 2008.
60. Strigo IA, Simmons AN, Matthews SC, Craig AD, Paulus MP: Major depressive disorder is associated with altered functional brain response during anticipation and processing of heat pain. Arch Gen Psychiatry 2008; 65: 1275-84.
61. Theobald DE, Kirsh KL, Holtsclaw E, Donaghy K, Passik SD: An open label cross-over trial of mirtazapine (15 and 30mg) in cancer patients with pain and other distressing symptoms. J Pain Symptom Manage 2002; 23: 442-7.
62. Tyrer S: Learned Pain Behaviour. BMJ 1986; 292: 1-2.
63. Vaccarino AL, Sills TL, Evans KR, Kalali AH: Prevalence and association of somatic symptoms in patient with major depressive disorder. J Affect Disord 2008; 110: 270-6.
64. Videbech P & Ravnklide B: Hippocampal volume and depression: a meta analysis of MRI studies. Am J Psychiatry 2004; 161: 1957-66.
65. Vossen H, Monsieur D, van Os J, Leue C: Serotoninnoradrenalin reuptake inhibitors in the treatment of nonmalignant pain syndromes: a systematic review. Tijdschr Psychiatr 2009; 51: 831-40.
66. Žunter-Nagy AM: Etiologija depresije In: Drinovec J. (ed.): Krka v medicini in farmaciji: Obravnava depresij v ambulanti zdravnika splošne prakse. 19 (suppl. 1): 14-20. Krka, Ljubljana, 1998.